Global Rheumatic Disorders Drug Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global rheumatic disorders drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Rheumatic disorders are a wide range of conditions that are characterized by chronic pain, with some of the most common conditions being osteoarthritis (OA) and rheumatoid arthritis (RA), and it is estimated that about one in four adults in America is diagnosed with a rheumatic disorder. The rheumatic disorder therapy area is multi-disciplinary and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion.
The majority of rheumatic
disorders are treated using largely genericized pain management drugs. The
incidence of many indications within the rheumatic disorders therapy area
continues to rise and as the global population ages prevalence will increase
which is a key driver of market growth. The market growth will also be driven
by the entry of new products to the market, with two drug classes, in
particular, driving the strong market growth.
To Request a Sample of our Report on Global Rheumatic
Disorders Drug Market: https://www.omrglobal.com/request-sample/rheumatic-disorders-drug-market
The global rheumatic disorders drug market analysis includes some of the
key market players such as AbbVie Inc, Amgen Inc., Johnson & Johnson
Services Inc., Novartis International AG, among others. To maintain a strong
position in the market, the market players are adopting various strategic moves,
such as product launches, partnerships and collaborations, and mergers and
acquisitions. For instance, in November 2021, Sandoz Egypt, in collaboration
with the Egyptian Orthopedic Association (EOA), has announced the launch of a
new non-steroidal anti-inflammatory drug (NSAID from Sandoz), etoricoxib, for
the treatment of arthritis and chronic rheumatic disorders symptoms.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: AbbVie Inc, Amgen Inc., Johnson & Johnson
Services Inc., Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Rheumatic Disorders Drug Market is Available
at: https://www.omrglobal.com/industry-reports/rheumatic-disorders-drug-market
Global Rheumatic Disorders Drug Market Report Segmentation
By Route of Administration
• Oral
• Parenteral
By Drug Class
• Disease-modifying
Anti-rheumatic Drugs (DMARDs)
• Nonsteroidal
Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Uric Acid Drugs
• Others
Global Rheumatic Disorders Drug Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment